epidem
control
rapid
identif
character
respons
unknown
agent
crucial
address
critic
question
method
develop
viru
discoveri
base
flexibl
nestedpcr
subtract
hybrid
posit
control
use
hepat
c
viru
hypothet
unrecogn
viru
discov
sampl
use
templateswitch
univers
longpcr
produc
larg
quantiti
cdna
nestedpcrbas
subtract
hybrid
coupl
singlestrand
delet
technolog
remov
common
cdna
follow
subtract
hybrid
cdna
librari
construct
display
differenti
revers
dot
blot
hybrid
new
genom
subtract
hybrid
method
ideal
suit
identifi
rapidli
previous
unrecogn
viral
agent
publish
elsevi
bv
base
past
histori
hypothet
risk
mani
peopl
infect
unrecogn
virus
time
new
viru
hepat
c
viru
hcv
human
immunodefici
viru
hiv
sever
acut
respiratori
syndrom
sar
associ
coronaviru
found
late
save
live
mani
individu
even
thousand
longerterm
solut
power
molecular
techniqu
need
rapidli
identifi
previous
unrecogn
viral
agent
without
use
viru
isol
method
could
appli
investig
futur
outbreak
recent
technolog
detect
identifi
previous
unrecogn
pathogen
differenti
display
represent
differ
analysi
subtract
hybrid
express
librari
screen
broadrang
polymeras
chain
reaction
pcr
serial
analysi
gene
express
timeconsum
reproduc
approach
alland
et
al
year
sinc
invent
differenti
display
liang
lisitsyn
et
al
subtract
hybrid
differenti
displaylik
technolog
approach
use
identifi
isol
cdna
differenti
express
gene
field
cancer
research
yen
su
et
al
methodolog
common
one
dna
popul
driver
hybrid
excess
second
popul
tester
dna
remov
sequenc
present
popul
project
adapt
method
mrna
analysi
rapidli
detect
gene
unknown
viru
purpos
subtract
hybridizationlik
method
singlestrand
delet
technolog
develop
hcv
use
hypothet
unrecogn
viru
studi
tradit
subtract
hybrid
often
requir
larg
amount
mrna
start
materi
commonli
challeng
problem
obtain
suffici
amount
mrna
viru
project
highqual
full
length
cdna
larg
quantiti
obtain
use
univers
longpcr
base
method
clontech
bd
usa
normal
subtract
hybrid
gener
librari
typic
contain
background
clone
repres
nondifferenti
gene
liang
overcom
problem
singlestrand
specif
mung
bean
endonucleas
pcr
use
ideal
suit
rapidli
reduc
number
fals
posit
could
aris
specif
singl
driver
strand
linear
amplifi
tester
strand
degrad
doubl
strand
product
exponenti
amplif
uniqu
tester
sequenc
remain
unaffect
reduc
background
pcr
product
nest
pcr
perform
use
nest
primer
enrich
differenti
produc
sequenc
tester
driver
subtract
cdna
librari
obtain
clone
directli
pgemt
clone
vector
plasmid
dna
random
select
clone
analyz
differenti
revers
dot
blot
hybrid
carri
determin
whether
uniqu
subtract
tester
product
repres
genom
region
hypothet
unknown
viru
case
hcv
hybrid
clone
sequenc
sequenc
correspond
hypothet
unknown
viru
hcv
recov
inclus
mung
bean
endonucleas
treatment
protocol
preclud
need
multipl
round
subtract
recent
year
method
pcr
amplif
long
dna
fragment
advanc
significantli
intrins
termin
transferas
activ
revers
transcriptas
rt
clontech
petalidi
et
al
long
pcr
capabl
gener
fulllength
cdna
librari
small
quantiti
rna
addit
combin
use
singlestrand
delet
technolog
subtract
hybrid
may
elimin
shorten
step
requir
tradit
method
method
improv
abil
respond
rapidli
infecti
diseas
outbreak
provid
ad
valu
event
bioterrorist
event
hypothet
unknown
viru
hcv
consid
unknown
mrna
studi
unknown
viru
mrna
sequenc
present
specimen
consid
tester
tester
hcv
infect
cell
line
type
specimen
obtain
environ
consid
driver
driver
noninfect
cell
line
larg
quantiti
cdna
produc
univers
longpcr
method
ideal
suit
subtract
abund
common
mrna
sequenc
present
popul
tester
driver
method
focus
small
number
unknown
viru
mrna
sequenc
present
specimen
enrich
stoichiometri
kinet
singlestrand
delet
technolog
limit
background
common
sequenc
subtract
cdna
librari
construct
display
differenti
revers
hybrid
dna
sequenc
character
human
acut
lymphoblast
leukemia
cell
line
obtain
origin
american
type
cultur
collect
atcc
rockvil
md
usa
lohmann
et
al
wellnitz
et
al
maintain
rpmi
atcc
modifi
medium
atcc
rockvil
md
usa
supplement
fetal
bovin
serum
atcc
rockvil
md
usa
cultur
flask
approxim
cellsml
vitro
infect
cell
line
perform
use
hcv
rnaposit
serum
chronic
hcv
carrier
cell
subcultur
regularli
split
everi
week
hu
et
al
total
cellular
rna
isol
cell
line
singlestep
extract
method
acid
guanidinium
thiocyanatephenolchloroform
mixtur
biotecx
laboratori
inc
houston
tx
usa
total
rna
remain
exclus
aqueou
phase
protein
dna
extract
organ
phase
interphas
total
rna
precipit
aqueou
phase
addit
equal
volum
isopropanol
wash
ethanol
solubil
rnase
free
water
rna
extract
special
care
taken
avoid
crosscontamin
separ
preand
postpcr
work
area
use
aerosolprov
tip
extract
small
aliquot
rna
product
run
gel
determin
qualiti
isol
total
rna
complet
high
qualiti
mrna
prepar
poli
tract
mrna
isol
system
iii
promega
madison
wi
usa
follow
manufactur
instruct
briefli
l
total
rna
heat
c
min
l
biotinylatedoligo
dt
probe
l
ssc
ad
incub
room
temperatur
complet
cool
entir
mixtur
ad
tube
contain
streptavidin
paramagnet
particl
incub
room
temperatur
min
mixtur
mrnabiotinyl
oligo
dt
probestreptavidin
paramagnet
particl
captur
magnet
stand
wash
four
time
ssc
mrna
elut
streptavidin
paramagnet
particl
l
rnasefre
water
use
templat
cdna
synthesi
templateswitch
activ
moloney
murin
leukemia
viru
mmlv
revers
transcriptas
modifi
oligo
dt
primer
use
synthes
fulllength
firststrand
cdna
use
smart
tm
pcr
cdna
synthesi
kit
follow
clontech
laboratori
palo
alto
ca
usa
mrna
mix
l
modifi
oligo
dt
primer
aag
cag
tgg
tat
caa
cgc
aga
gta
ct
n
l
templat
switch
primer
aag
cag
tgg
tat
caa
cgc
aga
gta
cgc
reaction
mixtur
incub
c
min
temperatur
reduc
c
follow
reagent
ad
l
strand
buffer
mm
trishcl
ph
mm
kcl
mm
mgcl
l
mm
dtt
l
mm
dntp
unit
rnase
inhibitor
appli
biosystem
foster
citi
ca
usa
l
mmlv
revers
transcriptas
reaction
mixtur
incub
c
min
perkinelm
dna
thermal
cycler
appli
biosystem
foster
citi
ca
usa
reaction
stop
ad
l
edta
order
remov
unincorpor
nucleotid
small
cdna
unus
fragment
cdna
product
purifi
use
nucleospin
extract
spin
column
accord
manufactur
instruct
clontech
laboratori
palo
alto
ca
usa
l
strand
cdna
use
templat
second
strand
synthesi
follow
reagent
ad
l
dh
l
pcr
buffer
bd
clontech
l
mm
dntp
l
pcr
primer
aag
cag
tgg
tat
caa
cgc
aga
l
polymeras
mix
reaction
mixtur
subject
follow
cycl
c
min
cycl
c
c
c
min
reaction
stop
ad
l
edta
cdna
extract
phenol
chloroform
isoamyl
alcohol
mix
purifi
column
chromatographi
small
aliquot
pcr
product
run
gel
determin
qualiti
fulllength
cdna
synthes
high
molecular
weight
smear
expect
long
sequenc
amplifi
less
effici
shorter
sequenc
tester
driver
cdna
digest
rsa
fourbasecut
restrict
enzym
yield
blunt
end
restrictionmapp
purifi
cdna
incub
unit
rsa
buffer
total
l
c
h
reaction
stop
ad
l
edta
digest
small
aliquot
rsa
digest
cdna
product
run
gel
confirm
digest
qualiti
tester
cdna
subdivid
two
portion
blunt
end
cdna
fragment
ligat
differ
unphosphoryl
adaptor
adaptor
cta
ata
cga
ctc
act
ata
ggg
ctc
gag
cgg
ccg
ccc
ggg
cag
gta
cct
gcc
adaptor
cta
ata
cga
ctc
act
ata
ggg
cag
cgt
ggt
cgc
ggc
cga
ggt
acc
tgc
ggc
clontech
bd
palo
alto
ca
usa
end
adaptor
phosphat
group
one
strand
adaptor
attach
end
cdna
evalu
ligat
effici
excess
driver
cdna
ad
sampl
tester
cdna
sampl
heat
denatur
c
min
allow
hybrid
c
h
second
hybrid
two
primari
hybrid
product
hybrid
mix
togeth
without
denatur
fresh
denatur
driver
cdna
ad
mix
second
hybrid
perform
c
h
l
dna
polymeras
l
pcr
buffer
l
dntp
ad
hybrid
product
fill
end
molecul
creat
doublestrand
primer
sequenc
anneal
site
pcr
molecul
uniqu
tester
amplicon
reanneal
form
doublestrand
molecul
pcr
prime
sequenc
end
abl
amplifi
exponenti
entir
popul
molecul
subject
pcr
amplifi
desir
differenti
express
sequenc
total
l
reaction
mixtur
pcr
buffer
dntp
polymeras
describ
one
pcr
primer
pcr
primer
cta
ata
cga
ctc
cat
ata
ggg
clontech
bd
palo
alto
ca
usa
mixtur
subject
cycl
pcr
dna
thermal
cycler
denatur
c
anneal
c
extens
c
min
mung
bean
nucleas
well
known
cleav
dna
region
singlestranded
kuvbachieva
goffinet
order
elimin
potenti
fals
posit
result
nest
pcr
pcr
product
treat
mung
bean
nucleas
promega
madison
wi
usa
l
reaction
buffer
mm
sodium
acet
mm
zncl
vv
glycerol
unit
mung
bean
nucleas
c
min
total
l
treatment
mung
bean
nucleas
mix
extract
phenol
twice
chloroform
ethanolprecipit
nh
oac
pellet
dissolv
l
mm
tri
ph
contain
mm
edta
ph
te
buffer
order
reduc
background
pcr
product
even
enrich
specif
uniqu
tester
cdna
secondari
pcr
amplif
perform
within
total
l
reaction
l
mung
bean
nucleas
treat
pcr
product
l
pcr
buffer
l
mm
dntp
l
polymeras
mix
two
nestedpcr
primer
nestedpcr
primer
tcg
agc
ggc
cgc
ccg
ggc
agg
nestedpcr
primer
agc
gtg
gtc
gcg
gcc
gag
clontech
bd
palo
alto
ca
usa
mixtur
subject
cycl
pcr
dna
thermal
cycler
denatur
c
anneal
c
extens
c
min
nestedpcr
amplif
subtract
cdna
insert
directli
ta
clone
vector
promega
madison
wi
usa
molecular
clone
perform
ligat
subtract
cdna
pgemt
clone
plasmid
vector
dna
ligas
atp
c
overnight
chimera
introduc
high
effici
compet
cell
transform
heat
shock
c
cdna
insert
detect
interrupt
code
sequenc
bluewhit
color
screen
lbampicilliniptgxg
indic
plate
posit
clone
randomli
select
work
multipl
digoxigenin
label
probe
prepar
tester
driver
doubl
strand
cdna
longpcr
triphosph
roch
indianapoli
usa
longpcr
reaction
rsa
digest
perform
describ
dna
randomli
select
clone
subtract
librari
prepar
use
miniprep
dna
purif
system
promeg
madison
wi
usa
blot
nylon
membran
intergen
purchas
nj
usa
potenti
interest
sequenc
detect
solid
phase
revers
hybrid
digoxigenin
label
probe
hybrid
dig
easi
hyb
solut
roch
indianapoli
usa
perform
nonstring
temperatur
c
ensur
probe
would
bind
clone
contain
similar
sequenc
highstring
wash
use
c
decreas
hybrid
background
duplic
membran
prepar
hybrid
clone
correspond
unknown
viral
cdna
hcv
hybrid
tester
probe
driver
probe
dna
select
clone
subject
cycl
sequenc
reaction
pmol
unlabl
promot
primer
qiagen
operon
alameda
ca
usa
termin
reaction
mixtur
accord
manufactur
instruct
appli
biosystem
foster
citi
ca
usa
cycl
sequenc
reaction
consist
cycl
dna
thermal
cycler
cycl
consist
denatur
c
anneal
c
extens
c
min
cycl
fluoresc
extens
product
purifi
simpl
isopropanol
precipit
step
dna
sequenc
data
analyz
chroma
program
helensval
queensland
australia
genbank
sequenc
databas
blast
program
nation
center
biotechnolog
inform
ncbi
import
appropri
control
studi
order
valid
procedur
human
placenta
rna
control
clontech
bd
palo
alto
ca
usa
use
parallel
tester
driver
rna
also
pcr
reaction
alway
carri
pcr
machin
optim
paramet
may
vari
differ
thermal
cycler
agaros
gel
sybr
green
stain
molecular
probe
eugen
usa
research
start
poli
rna
hcv
infect
noninfect
cell
line
tradit
revers
transcriptas
alway
transcrib
entir
mrna
sequenc
use
rnase
h
point
mutant
mmlv
revers
transcriptas
enzym
reach
end
mrna
special
bind
oligonucleotid
end
cap
structur
allow
synthesi
fulllength
cdna
clontech
laboratori
palo
alto
ca
usa
larg
quantiti
full
length
cdna
produc
long
pcr
result
confirm
long
target
full
length
cdna
endtoend
amplifi
directli
cdna
strand
cdna
digest
rsai
creat
blunt
end
cdna
fragment
kinet
theori
behind
subtract
hybrid
hybrid
associ
rate
import
studi
basic
subtract
hybrid
subtract
dna
enrich
techniqu
methodolog
common
one
dna
popul
driver
hybrid
excess
second
popul
tester
remov
sequenc
present
popul
therebi
enrich
target
sequenc
uniqu
tester
theori
standard
condit
subtract
hybrid
second
order
kinet
hybrid
cc
kc
k
secondord
hybrid
rate
constant
c
surfac
concentr
cdna
c
initi
concentr
cdna
solut
miner
et
al
toweri
et
al
wang
drlica
hybrid
reaction
reanneal
faster
abund
molecul
concentr
high
driver
cdna
low
tester
cdna
becom
roughli
equal
base
theori
tester
cdna
significantli
enrich
studi
two
differ
adaptor
ligat
tester
cdna
molecul
first
hybrid
reaction
significantli
enrich
uniqu
sequenc
found
tester
cdna
due
second
order
kinet
hybrid
describ
second
hybrid
reaction
gener
three
major
molecular
type
cdna
without
adaptor
cdna
without
adaptor
would
probabl
combin
reanneal
due
excess
unlig
driver
cdna
cdna
would
amplifi
pcr
due
absenc
ligat
adaptor
cdna
adaptor
tester
cdna
without
adaptor
driver
would
second
probabl
combin
due
excess
cdna
without
adaptor
ligat
cdna
would
amplifi
pcr
product
would
amplifi
thu
would
linear
amplif
uniqu
cdna
adaptor
reanneal
uniqu
cdna
adaptor
tester
would
least
like
combin
occur
uniqu
sequenc
found
tester
cdna
cdna
would
amplifi
exponenti
pcr
primer
bind
site
present
strand
newli
amplifi
strand
also
contain
primer
sequenc
target
cdna
enrich
repeat
cycl
pcr
nestedpcr
testertest
duplex
two
differ
adaptor
primer
sequenc
end
amplifi
exponenti
equal
differenti
express
sequenc
pcr
molecul
miss
primer
anneal
site
thu
could
amplifi
discuss
order
elimin
fals
posit
background
tradit
subtract
hybrid
protocol
modifi
pcr
product
treat
specif
mung
bean
nucleas
nestedpcr
amplif
driver
strand
linear
amplifi
tester
strand
singlestrand
degrad
select
amplifi
product
remain
unaffect
control
experi
carri
without
mung
bean
nucleas
treatment
signific
posit
clone
found
first
round
subtract
hybrid
transform
compet
ecoli
cell
bluewhit
select
iptg
plate
transform
bacteria
white
coloni
individu
randomli
pick
amplicilin
plate
chimer
dna
directli
extract
use
miniprep
dna
purif
system
without
tradit
amplif
delet
present
studi
select
cdna
clone
use
experi
detect
potenti
interest
sequenc
solid
phase
revers
hybrid
clone
consid
correspond
unknown
viral
cdna
hybrid
tester
probe
eg
clone
fig
clone
hybrid
tester
driver
probe
exclud
duplic
membran
prepar
hybrid
similar
result
obtain
standard
protocol
subtract
hybrid
necessari
multipl
round
enrich
differenti
sequenc
studi
use
longpcr
produc
larg
amount
cdna
conjunct
mung
bean
nucleas
treatment
decreas
background
possibl
detect
unknown
viru
cdna
one
round
subtract
hybrid
revers
dot
blot
hybrid
potenti
posit
clone
directli
sequenc
use
abi
prism
bigdy
termin
cycl
sequenc
readi
reaction
kit
version
abi
prism
genet
analyz
appli
biosystem
foster
citi
ca
usa
accord
manufactur
instruct
clone
contain
tester
specif
fragment
recov
new
subtract
hybrid
subtract
librari
uniqu
tester
specif
fragment
detect
randomli
select
clone
sequenc
analysi
select
clone
show
correspond
known
hcv
gene
thu
random
select
clone
four
insert
could
ascrib
hcv
genom
remain
clone
demonstr
signific
match
entri
databas
may
nonspecif
chimer
fragment
incomplet
digest
fragment
mani
human
diseas
unknown
etiolog
may
caus
unrecogn
virus
detect
character
remain
major
challeng
virologist
clinician
investig
outbreak
caus
unknown
viru
rapid
identif
character
must
high
prioriti
relationship
potenti
new
infecti
agent
known
viru
establish
sequenc
appropri
cultur
condit
serolog
test
nucleic
acid
detect
even
therapeut
strategi
rapidli
develop
molecular
analysi
unknown
virus
proceed
slowli
date
highli
reproduc
test
model
develop
current
method
laborintens
cumbersom
problem
extrem
small
quantiti
viral
mrna
present
comparison
host
mrna
although
tradit
subtract
hybrid
method
success
case
requir
larg
quantiti
mrna
start
materi
sever
round
hybrid
kellam
weiss
well
suit
identif
unrecogn
uncharacter
viral
agent
obtain
fulllength
cdna
one
import
often
one
difficult
step
subtract
hybrid
prepar
fulllength
cdna
librari
rapid
discoveri
new
viru
still
remain
challeng
field
studi
use
success
templateswitch
activ
mmlv
revers
transcriptas
modifi
oligo
dt
primer
synthes
fulllength
firststrand
cdna
start
materi
order
prepar
larg
quantiti
cdna
success
use
longpcr
gener
suffici
quantiti
tester
driver
cdna
sampl
subtract
hybrid
method
remov
common
cdna
nestedpcrbas
subtract
hybrid
singlestrand
delet
technolog
reduc
number
fals
posit
step
overcom
technic
limit
tradit
subtract
method
also
show
longpcr
cdna
product
use
directli
hybrid
probe
screen
subtract
cdna
librari
conclus
subtract
hybrid
procedur
use
long
pcr
fulllength
cdna
prepar
singlestrand
delet
technolog
success
develop
project
use
hcv
infect
cell
line
tester
uninfect
cell
line
driver
sever
hcv
cdna
fragment
recov
result
indic
subtract
hybrid
method
high
sensit
low
background
rapid
simpl
reliabl
protocol
emerg
diseas
sar
defens
bioterrorist
attack
rapid
identif
character
respons
agent
crucial
first
step
effici
techniqu
repres
valuabl
tool
discoveri
unrecogn
uncharacter
viral
agent
present
low
copi
number
highli
complex
background
